Nantahala Capital Management
Nantahala Capital Management reported 131 stocks worth $3.3B in its 13F filing for Q2 2026, filed Aug 19, 2026. Its largest holdings are TBBK (4.7%), BVS (3.4%) and HGV (3.3%). Compared with Q1 2026, the fund opened new positions in ADMA, VOR and PLNT, added to TBBK, BVS and HGV, trimmed PTON, ESTA and TNGX and sold out of COGT, SLDB and DNTH.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  TBBK Bancorp Inc Del | $155M | 4.7% | 2.5M | +1.1M (+80%) | 8 of 8 | |
| 2 |  BVS Bioventus Inc | $113M | 3.4% | 12M | +5.9M (+96%) | 8 of 8 | |
| 3 |  HGV Hilton Grand Vacations Inc | $108M | 3.3% | 2.1M | +553K (+37%) | 8 of 8 | |
| 4 |  SVRA Savara Inc | $86M | 2.6% | 14M | +6.6M (+90%) | 8 of 8 | |
| 5 |  ETON Eton Pharmaceuticals Inc | $85.1M | 2.6% | 2.4M | +1.2M (+100%) | 8 of 8 | |
| 6 |  AMRX Amneal Pharmaceuticals Inc | $78.5M | 2.4% | 4.5M | +1.7M (+60%) | 8 of 8 | |
| 7 |  EOLS Evolus Inc | $77.8M | 2.4% | 11.2M | +4.8M (+76%) | 8 of 8 | |
| 8 |  AVTX Avalo Therapeutics Inc | $68.8M | 2.1% | 3.7M | +2.5M (+202%) | 6 of 8 | |
| 9 |  LBRX LB Pharmaceuticals Inc | $68.3M | 2.1% | 2.1M | +1.1M (+100%) | 4 of 8 | |
| 10 |  AVR Anteris Technologies Global | $66.7M | 2.0% | 6.8M | +1.2M (+22%) | 7 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
SOLENO THERAPEUTICS INC | $58.4M | 1.7M |
ASSERTIO HLDGS INC | $13.2M | 692K |
CENTESSA PHARMACEUTICALS PLC | $10.1M | 255K |
 COGT Cogent Biosciences Inc | $9.6M | 250K |
 SLDB Solid Biosciences Inc | $8.4M | 1.2M |
🔒 Free account: see all 20.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 IWM Ishares TR | Put | $1.2B | 4M | +1,950,000 |
 PTON Peloton Interactive Inc | Call | $194M | 32.9M | +14,938,900 |
 HLF Herbalife Ltd | Call | $174M | 13.2M | +7,600,000 |
 VTRS Viatris Inc | Call | $159M | 10M | +5,000,000 |
 EW Edwards Lifesciences Cor | Put | $145M | 1.6M | +800,000 |
🔒 Free account: see all 20.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 19, 2026 | 13F-HR/A Amendment | Q2 2026 | SEC filing ↗ |
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Includes an amendment, which can add positions the fund kept confidential at first, or replace the original report.
Other superinvestors
All hedge fund holdings →Nantahala Capital Management 13F FAQ
What does Nantahala Capital Management own?
Nantahala Capital Management reported 131 stocks worth $3.3B in its 13F filing for Q2 2026, filed Aug 19, 2026. Its largest holdings are TBBK (4.7%), BVS (3.4%) and HGV (3.3%). The table above lists every position in the filing (the top 10 without an account).
What did Nantahala Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 22 new positions, 102 added to, 7 trimmed and 20 sold out. New positions include ADMA, VOR and PLNT. It sold all of COGT, SLDB and DNTH.
When will Nantahala Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Nantahala Capital Management's portfolio worth?
The Q2 2026 filing reports $3.3B in US stocks ($6B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.